

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * oxygen transport (GO:0015671) | 7.72956230 |
| 2 | * gas transport (GO:0015669) | 6.33519158 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.74997258 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.74997258 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.74997258 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.74997258 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.74997258 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.74997258 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.72478360 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.57634452 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.57634452 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.32004968 |
| 13 | detection of other organism (GO:0098543) | 5.17332427 |
| 14 | detection of bacterium (GO:0016045) | 5.16899605 |
| 15 | response to peptidoglycan (GO:0032494) | 4.85801058 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71300508 |
| 17 | neutrophil activation (GO:0042119) | 4.61501907 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.58068206 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.56885063 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.49279369 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.40365581 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.22069242 |
| 23 | respiratory burst (GO:0045730) | 4.20150975 |
| 24 | granulocyte activation (GO:0036230) | 4.19099674 |
| 25 | response to interleukin-15 (GO:0070672) | 4.19046591 |
| 26 | cellular extravasation (GO:0045123) | 4.16089859 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.09247259 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.09022891 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.06818593 |
| 30 | response to host immune response (GO:0052572) | 4.06818593 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.05058566 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.01986937 |
| 33 | leukocyte aggregation (GO:0070486) | 3.91818995 |
| 34 | negative regulation of phagocytosis (GO:0050765) | 3.91621676 |
| 35 | neutrophil mediated immunity (GO:0002446) | 3.91464227 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.83623583 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.83106304 |
| 38 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.79506211 |
| 39 | erythrocyte maturation (GO:0043249) | 3.73790458 |
| 40 | microglial cell activation (GO:0001774) | 3.73768006 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.73359155 |
| 42 | response to host (GO:0075136) | 3.73359155 |
| 43 | response to host defenses (GO:0052200) | 3.73359155 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72119905 |
| 45 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.71764179 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 3.68787073 |
| 47 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.67344033 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64781549 |
| 49 | hemoglobin metabolic process (GO:0020027) | 3.64540022 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.64435700 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.62467348 |
| 52 | detection of biotic stimulus (GO:0009595) | 3.61804890 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57717661 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.53754420 |
| 55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51447020 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 3.51086423 |
| 57 | erythrocyte development (GO:0048821) | 3.46495500 |
| 58 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.41789641 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40952058 |
| 60 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40434906 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38129957 |
| 62 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.36028449 |
| 63 | leukocyte degranulation (GO:0043299) | 3.32443741 |
| 64 | macrophage activation (GO:0042116) | 3.31063514 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.30947212 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 3.26280353 |
| 67 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23295444 |
| 68 | regulation of B cell differentiation (GO:0045577) | 3.19859333 |
| 69 | negative regulation of interleukin-6 production (GO:0032715) | 3.19612866 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 3.18676062 |
| 71 | myeloid cell development (GO:0061515) | 3.17893910 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.15553295 |
| 73 | regulation of platelet aggregation (GO:0090330) | 3.15153585 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.14889263 |
| 75 | cellular response to type I interferon (GO:0071357) | 3.14889263 |
| 76 | response to type I interferon (GO:0034340) | 3.14631425 |
| 77 | tolerance induction (GO:0002507) | 3.14098732 |
| 78 | germinal center formation (GO:0002467) | 3.11618957 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 3.08994210 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.06622574 |
| 81 | regulation of mast cell activation (GO:0033003) | 3.04664744 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.00095293 |
| 83 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.98828073 |
| 84 | response to muramyl dipeptide (GO:0032495) | 2.98173544 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94789102 |
| 86 | positive thymic T cell selection (GO:0045059) | 2.94041667 |
| 87 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91447615 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 2.91110472 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91091479 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91091479 |
| 91 | megakaryocyte development (GO:0035855) | 2.90091561 |
| 92 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.88575899 |
| 93 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.88575899 |
| 94 | regulation of regulated secretory pathway (GO:1903305) | 2.88006804 |
| 95 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.87542185 |
| 96 | regulation of granulocyte differentiation (GO:0030852) | 2.86095454 |
| 97 | negative regulation of type 2 immune response (GO:0002829) | 2.84345505 |
| 98 | negative thymic T cell selection (GO:0045060) | 2.83961472 |
| 99 | modulation by virus of host process (GO:0019054) | 2.82610691 |
| 100 | superoxide anion generation (GO:0042554) | 2.82028670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.29637752 |
| 2 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.67372873 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.37182204 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.25814113 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.23895523 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.13092918 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.11349821 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.96868589 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84167505 |
| 10 | GATA1_19941826_ChIP-Seq_K562_Human | 2.78431830 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.76519308 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63966127 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.61657893 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60261588 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.58102630 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.58073507 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56995362 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.54633934 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.54416052 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53709578 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.38642453 |
| 22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.37824446 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36273749 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34664590 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34550627 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.29321110 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22959751 |
| 28 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.19932802 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.19017211 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.17160195 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.16163780 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.16052522 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.09395714 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08627046 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07109090 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07025339 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02302444 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00987311 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99318190 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.99208470 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98890086 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97047425 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.90670696 |
| 44 | GATA2_19941826_ChIP-Seq_K562_Human | 1.86927876 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86715053 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79581713 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74328524 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73783901 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.72416396 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68515713 |
| 51 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59102197 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58657191 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58552844 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55248995 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52567250 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52219928 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49271417 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49156369 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47033998 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46666932 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45227395 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42664983 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40457842 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39212911 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39052651 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37957313 |
| 67 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.37622672 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37265024 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34224373 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31110932 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30977734 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30743285 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30367345 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28571650 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27691409 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27481256 |
| 77 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.23965521 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23618534 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23579115 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22038139 |
| 81 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.21723110 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18222761 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13279818 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11930683 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11670726 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11336349 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11053861 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09654747 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04986639 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04935734 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02488973 |
| 92 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01537968 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00264593 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.99764047 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99285873 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99121835 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98319631 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96972816 |
| 99 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96369144 |
| 100 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92957224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.42706368 |
| 2 | MP0003436_decreased_susceptibility_to | 4.18155891 |
| 3 | MP0003303_peritoneal_inflammation | 3.89471163 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 3.22577846 |
| 5 | MP0002419_abnormal_innate_immunity | 3.04331875 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.98706892 |
| 7 | MP0005025_abnormal_response_to | 2.82461528 |
| 8 | MP0000685_abnormal_immune_system | 2.68677464 |
| 9 | MP0001790_abnormal_immune_system | 2.66366532 |
| 10 | MP0005387_immune_system_phenotype | 2.66366532 |
| 11 | MP0009785_altered_susceptibility_to | 2.66081859 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.54718173 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.54315212 |
| 14 | MP0001800_abnormal_humoral_immune | 2.53164887 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.49331332 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.40765682 |
| 17 | MP0001819_abnormal_immune_cell | 2.37547577 |
| 18 | MP0005083_abnormal_biliary_tract | 2.37038661 |
| 19 | MP0005671_abnormal_response_to | 2.31460514 |
| 20 | MP0002723_abnormal_immune_serum | 2.28886254 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.25414792 |
| 22 | MP0002132_abnormal_respiratory_system | 2.22706699 |
| 23 | MP0008260_abnormal_autophagy | 2.21245352 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.15280254 |
| 25 | MP0004147_increased_porphyrin_level | 2.14468121 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.13859026 |
| 27 | MP0009278_abnormal_bone_marrow | 2.13671731 |
| 28 | MP0002405_respiratory_system_inflammati | 2.11875799 |
| 29 | MP0002398_abnormal_bone_marrow | 2.10881001 |
| 30 | MP0006082_CNS_inflammation | 2.09182423 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.99635355 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.99635355 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.95391922 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.93529907 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.84019519 |
| 36 | MP0000716_abnormal_immune_system | 1.82423274 |
| 37 | MP0003045_fibrosis | 1.78994286 |
| 38 | MP0002722_abnormal_immune_system | 1.73651588 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.70308571 |
| 40 | MP0003828_pulmonary_edema | 1.69493125 |
| 41 | MP0003866_abnormal_defecation | 1.67241812 |
| 42 | MP0003878_abnormal_ear_physiology | 1.63832395 |
| 43 | MP0005377_hearing/vestibular/ear_phenot | 1.63832395 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.63650161 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.63158635 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.59013928 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.58394164 |
| 48 | MP0002429_abnormal_blood_cell | 1.58160308 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.56573580 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.53188836 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.50981633 |
| 52 | MP0004947_skin_inflammation | 1.46569019 |
| 53 | MP0004381_abnormal_hair_follicle | 1.41739982 |
| 54 | MP0001851_eye_inflammation | 1.40750768 |
| 55 | MP0009764_decreased_sensitivity_to | 1.39691883 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.34617336 |
| 57 | MP0008469_abnormal_protein_level | 1.33637568 |
| 58 | MP0005310_abnormal_salivary_gland | 1.21976848 |
| 59 | MP0005451_abnormal_body_composition | 1.21944295 |
| 60 | MP0000858_altered_metastatic_potential | 1.19992380 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.10349967 |
| 62 | MP0004883_abnormal_blood_vessel | 1.09567011 |
| 63 | MP0004510_myositis | 1.02969395 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.01808214 |
| 65 | MP0000490_abnormal_crypts_of | 0.99167617 |
| 66 | MP0003075_altered_response_to | 0.95259424 |
| 67 | MP0002998_abnormal_bone_remodeling | 0.92798753 |
| 68 | MP0005164_abnormal_response_to | 0.90943883 |
| 69 | MP0001663_abnormal_digestive_system | 0.89338737 |
| 70 | MP0009763_increased_sensitivity_to | 0.88594763 |
| 71 | MP0001873_stomach_inflammation | 0.87811742 |
| 72 | MP0000343_altered_response_to | 0.87700144 |
| 73 | MP0004130_abnormal_muscle_cell | 0.85649831 |
| 74 | MP0002166_altered_tumor_susceptibility | 0.83795981 |
| 75 | MP0003690_abnormal_glial_cell | 0.78337996 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.76336579 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.75956090 |
| 78 | MP0005390_skeleton_phenotype | 0.74756856 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.71536174 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.69985008 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.69111589 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.68257523 |
| 83 | MP0003795_abnormal_bone_structure | 0.67721124 |
| 84 | MP0005166_decreased_susceptibility_to | 0.64549224 |
| 85 | MP0008004_abnormal_stomach_pH | 0.64409991 |
| 86 | MP0002653_abnormal_ependyma_morphology | 0.63082566 |
| 87 | MP0008874_decreased_physiological_sensi | 0.61480480 |
| 88 | MP0009931_abnormal_skin_appearance | 0.60638869 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.59821642 |
| 90 | MP0000249_abnormal_blood_vessel | 0.59696003 |
| 91 | MP0002168_other_aberrant_phenotype | 0.59132530 |
| 92 | MP0002928_abnormal_bile_duct | 0.57411997 |
| 93 | MP0000609_abnormal_liver_physiology | 0.56505006 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.56113628 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53965577 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.53463335 |
| 97 | MP0002933_joint_inflammation | 0.53012438 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.52380449 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.52006693 |
| 100 | MP0003448_altered_tumor_morphology | 0.50924370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.98171727 |
| 2 | * Hypochromic anemia (HP:0001931) | 6.62458471 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.34486027 |
| 4 | * Abnormal hemoglobin (HP:0011902) | 5.61801983 |
| 5 | * Microcytic anemia (HP:0001935) | 5.44537882 |
| 6 | Recurrent abscess formation (HP:0002722) | 5.44010321 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.30019753 |
| 8 | Myositis (HP:0100614) | 4.81695506 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.75926090 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.62394512 |
| 11 | Stomatitis (HP:0010280) | 4.61689076 |
| 12 | Orchitis (HP:0100796) | 4.30879082 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.11836609 |
| 14 | Obstructive lung disease (HP:0006536) | 4.11836609 |
| 15 | Prolonged bleeding time (HP:0003010) | 4.07335150 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99659474 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.89406773 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.86472870 |
| 19 | Optic neuritis (HP:0100653) | 3.77574435 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.77574435 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.74487595 |
| 22 | Increased IgE level (HP:0003212) | 3.61934388 |
| 23 | Urticaria (HP:0001025) | 3.61719731 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.60732473 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.56362335 |
| 26 | Poikilocytosis (HP:0004447) | 3.54365426 |
| 27 | Meningitis (HP:0001287) | 3.46015080 |
| 28 | * Polycythemia (HP:0001901) | 3.41004169 |
| 29 | Recurrent skin infections (HP:0001581) | 3.40516498 |
| 30 | Gingivitis (HP:0000230) | 3.38975182 |
| 31 | Cellulitis (HP:0100658) | 3.19643969 |
| 32 | * Toxemia of pregnancy (HP:0100603) | 3.16676772 |
| 33 | Encephalitis (HP:0002383) | 3.14187591 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.04658736 |
| 35 | Osteomyelitis (HP:0002754) | 3.00581506 |
| 36 | Petechiae (HP:0000967) | 3.00262808 |
| 37 | Episodic fever (HP:0001954) | 2.97843145 |
| 38 | Abnormality of iron homeostasis (HP:0011031) | 2.96170038 |
| 39 | Epistaxis (HP:0000421) | 2.92298679 |
| 40 | Vasculitis (HP:0002633) | 2.90984594 |
| 41 | Gingival bleeding (HP:0000225) | 2.90451757 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87854638 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87854638 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.81182412 |
| 45 | Chest pain (HP:0100749) | 2.79273659 |
| 46 | Pustule (HP:0200039) | 2.72921138 |
| 47 | Cholelithiasis (HP:0001081) | 2.70431956 |
| 48 | Anorexia (HP:0002039) | 2.65253783 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.65245581 |
| 50 | Peritonitis (HP:0002586) | 2.62063005 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.58857184 |
| 52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.55327349 |
| 53 | Reticulocytosis (HP:0001923) | 2.52461269 |
| 54 | Abnormal platelet volume (HP:0011876) | 2.50291137 |
| 55 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.45440054 |
| 56 | Leukocytosis (HP:0001974) | 2.43917079 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.38726534 |
| 58 | Increased IgM level (HP:0003496) | 2.32978834 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.31452317 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.28345180 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 2.26113812 |
| 62 | Granulocytopenia (HP:0001913) | 2.25678381 |
| 63 | Hemoptysis (HP:0002105) | 2.23141701 |
| 64 | Abnormality of T cells (HP:0002843) | 2.21871854 |
| 65 | Recurrent viral infections (HP:0004429) | 2.21683194 |
| 66 | T lymphocytopenia (HP:0005403) | 2.19436609 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.15827867 |
| 68 | Abnormality of T cell number (HP:0011839) | 2.14367549 |
| 69 | Purpura (HP:0000979) | 2.13941786 |
| 70 | Pulmonary embolism (HP:0002204) | 2.11807686 |
| 71 | Abnormality of the fingertips (HP:0001211) | 2.10951012 |
| 72 | Sepsis (HP:0100806) | 2.07278342 |
| 73 | Arterial thrombosis (HP:0004420) | 2.06952897 |
| 74 | Difficulty running (HP:0009046) | 2.02008338 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.01959695 |
| 76 | Metaphyseal cupping (HP:0003021) | 2.00427313 |
| 77 | * Hypochromic microcytic anemia (HP:0004840) | 10.7237803 |
| 78 | Lymphopenia (HP:0001888) | 1.99766169 |
| 79 | Amyloidosis (HP:0011034) | 1.99731857 |
| 80 | Skin ulcer (HP:0200042) | 1.98283309 |
| 81 | Increased serum ferritin (HP:0003281) | 1.98007966 |
| 82 | Acanthocytosis (HP:0001927) | 1.96217978 |
| 83 | Thrombophlebitis (HP:0004418) | 1.95595101 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 1.91752044 |
| 85 | * Abnormality of the pericardium (HP:0001697) | 1.91520234 |
| 86 | Hepatosplenomegaly (HP:0001433) | 1.91269361 |
| 87 | Abnormality of the pleura (HP:0002103) | 1.86926315 |
| 88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85684265 |
| 89 | * Pallor (HP:0000980) | 1.79514954 |
| 90 | Glomerulopathy (HP:0100820) | 1.78888097 |
| 91 | IgM deficiency (HP:0002850) | 1.78860381 |
| 92 | * Splenomegaly (HP:0001744) | 1.76267306 |
| 93 | Paralysis (HP:0003470) | 1.74567525 |
| 94 | Acne (HP:0001061) | 1.73609883 |
| 95 | Hypertensive crisis (HP:0100735) | 1.72371965 |
| 96 | Colitis (HP:0002583) | 1.72126726 |
| 97 | Paresthesia (HP:0003401) | 1.71619157 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 1.70349340 |
| 99 | Eosinophilia (HP:0001880) | 1.69711169 |
| 100 | Vertigo (HP:0002321) | 1.68911437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.60912502 |
| 2 | MAP2K3 | 3.72282520 |
| 3 | MAP4K1 | 3.51649852 |
| 4 | ERN1 | 3.11448549 |
| 5 | IRAK4 | 3.04935201 |
| 6 | TNK2 | 3.02565065 |
| 7 | GRK6 | 2.98711797 |
| 8 | TAOK1 | 2.78372785 |
| 9 | PRPF4B | 2.72680670 |
| 10 | BLK | 2.55928722 |
| 11 | FES | 2.38346905 |
| 12 | MAP3K3 | 2.37932879 |
| 13 | MAP3K11 | 2.36843749 |
| 14 | TYK2 | 2.24410835 |
| 15 | CSK | 2.17532467 |
| 16 | EPHB1 | 2.11044707 |
| 17 | ZAP70 | 1.94063689 |
| 18 | BTK | 1.82982055 |
| 19 | HCK | 1.74630435 |
| 20 | TAOK2 | 1.72897551 |
| 21 | SYK | 1.70419777 |
| 22 | FGR | 1.60754811 |
| 23 | SIK3 | 1.50856842 |
| 24 | MAP3K1 | 1.47180190 |
| 25 | TXK | 1.44949917 |
| 26 | JAK3 | 1.32184473 |
| 27 | KSR2 | 1.31616467 |
| 28 | MARK3 | 1.29976063 |
| 29 | TRIB3 | 1.29934461 |
| 30 | LYN | 1.27550892 |
| 31 | JAK2 | 1.26608866 |
| 32 | MARK2 | 1.23091706 |
| 33 | IKBKE | 1.21824865 |
| 34 | PTK2B | 1.10970598 |
| 35 | PRKD2 | 1.10807801 |
| 36 | SIK2 | 1.06625817 |
| 37 | YES1 | 1.04864176 |
| 38 | LCK | 1.02844801 |
| 39 | PTK6 | 1.00472827 |
| 40 | TBK1 | 1.00088903 |
| 41 | SMG1 | 0.96588089 |
| 42 | TAOK3 | 0.89854717 |
| 43 | EIF2AK1 | 0.87318279 |
| 44 | JAK1 | 0.85483848 |
| 45 | HIPK2 | 0.85341060 |
| 46 | TEC | 0.84454590 |
| 47 | CDK19 | 0.82948500 |
| 48 | ITK | 0.82591768 |
| 49 | MAP3K6 | 0.82042376 |
| 50 | STK11 | 0.79705754 |
| 51 | KIT | 0.79051723 |
| 52 | MAP3K13 | 0.77685474 |
| 53 | BMX | 0.76821039 |
| 54 | PDK1 | 0.76675960 |
| 55 | MAP3K7 | 0.76316420 |
| 56 | CSF1R | 0.75672184 |
| 57 | SIK1 | 0.73670679 |
| 58 | SGK3 | 0.73499226 |
| 59 | PIM1 | 0.73329047 |
| 60 | MAP2K4 | 0.71254136 |
| 61 | MAPK12 | 0.70790831 |
| 62 | PDPK1 | 0.70483303 |
| 63 | STK10 | 0.68911756 |
| 64 | MAP3K14 | 0.68340444 |
| 65 | STK38 | 0.68182915 |
| 66 | TESK2 | 0.66689185 |
| 67 | MAP3K5 | 0.63489240 |
| 68 | DYRK1B | 0.63076303 |
| 69 | FYN | 0.61957225 |
| 70 | IKBKB | 0.60929237 |
| 71 | MAP3K2 | 0.59653839 |
| 72 | LRRK2 | 0.57280116 |
| 73 | RPS6KL1 | 0.54942414 |
| 74 | RPS6KC1 | 0.54942414 |
| 75 | IRAK1 | 0.54088246 |
| 76 | MATK | 0.51723941 |
| 77 | CDK12 | 0.51141592 |
| 78 | SGK2 | 0.50173148 |
| 79 | PRKCQ | 0.48249338 |
| 80 | RPS6KA6 | 0.46750009 |
| 81 | WNK1 | 0.46648928 |
| 82 | RET | 0.46128839 |
| 83 | DYRK3 | 0.44680305 |
| 84 | KSR1 | 0.44357324 |
| 85 | MAPKAPK2 | 0.42945093 |
| 86 | CLK1 | 0.42653677 |
| 87 | MAP3K8 | 0.41740367 |
| 88 | IRAK2 | 0.40818750 |
| 89 | MAPK7 | 0.40639340 |
| 90 | BMPR2 | 0.39023475 |
| 91 | PRKG2 | 0.37874458 |
| 92 | MAP3K10 | 0.37444888 |
| 93 | RAF1 | 0.36679378 |
| 94 | EPHA3 | 0.36589878 |
| 95 | CDC42BPA | 0.35093332 |
| 96 | PIK3CG | 0.34762830 |
| 97 | PRKCZ | 0.34296105 |
| 98 | DAPK2 | 0.32991036 |
| 99 | NLK | 0.32777135 |
| 100 | TGFBR2 | 0.31706041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Malaria_Homo sapiens_hsa05144 | 3.23339504 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.06172283 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71738714 |
| 4 | * African trypanosomiasis_Homo sapiens_hsa05143 | 2.42041716 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37645094 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.26581686 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.24930209 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24153641 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.17070403 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09545072 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.98839115 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91585596 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.88626964 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.81981689 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78523731 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.75898557 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73279789 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62841764 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61484778 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.60957757 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58833342 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.52802115 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43315398 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.42928848 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42768454 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.42360843 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41615081 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40723261 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38608303 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36309861 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35757472 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.34581345 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.28159093 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25047064 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.20743958 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.20057396 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18719183 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.16117902 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13915508 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.09644950 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08176283 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07350058 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.05183883 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99006912 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97222119 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95423242 |
| 47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95356696 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.93263482 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92771504 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.91974716 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89713975 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.89560523 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 0.88891572 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88866380 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88843697 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84912414 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83575540 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82543633 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80823831 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.80438577 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80192795 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80122397 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78291900 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77998093 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77487088 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76085061 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75585742 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74242594 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73792022 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73698698 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73482719 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72221214 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.69713967 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69248146 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68358256 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67313321 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67243737 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65454093 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65190210 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63897776 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63235475 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62732848 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61705534 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61351315 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59741976 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.58185465 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56489006 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.55559809 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54945286 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54528553 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54360410 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53307593 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52956028 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50564593 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.50329067 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50152191 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49763436 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.49088479 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47402690 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46632321 |

